Related Experiment Video
Updated: Jan 29, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
Published on: November 4, 2016
In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their
Nina Schleimer1, Ursula Kaspar2, Dennis Knaack3
1Institute of Medical Microbiology, University Hospital Münster (UKM), 48149 Münster, Germany. nina.schleimer@ukmuenster.de.
Abstract:
Nasal carriage of methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) represents both a source and a risk factor for subsequent infections. However, existing MRSA decolonization strategies and antibiotic treatment options are hampered by the duration of administration and particularly by the emergence of resistance. Moreover, beyond classical resistance mechanisms, functional resistance as the formation of the small-colony variant (SCV) phenotype may also impair the course and treatment of S. aureus infections. For the recombinant bacteriophage endolysin HY-133, rapid bactericidal and highly selective in vitro activities against MSSA and MRSA has been shown. In order to assess the in vitro efficacy of HY-133 against the SCV phenotype, minimal inhibitory (MIC) and minimal bactericidal concentrations (MBC) were evaluated on clinical SCVs, their isogenic wild types, as well as on genetically derived and gentamicin-selected SCVs. For all strains and growth phases, HY-133 MIC and MBC ranged between 0.12 and 1 mg/L. Time-kill studies revealed a fast-acting bactericidal activity of HY-133 resulting in a ≥3 - log10 decrease in CFU/mL within 1 h compared to oxacillin, which required 4⁻24 h. Since the mode of action of HY-133 was independent of growth phase, resistance pattern, and phenotype, it is a promising candidate for future S. aureus decolonization strategies comprising rapid activity against phenotypic variants exhibiting functional resistance.
Insights
Recombinant bacteriophage endolysin HY-133 shows rapid bactericidal activity against methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA), including small-colony variants. This endolysin offers a promising, fast-acting alternative for Staphylococcus aureus decolonization strategies.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Nasal carriage of Staphylococcus aureus (MSSA and MRSA) is a significant risk factor for infections.
- Current decolonization and antibiotic treatments face challenges due to administration duration and emerging resistance, including functional resistance via small-colony variants (SCVs).
Purpose of the Study:
- To evaluate the in vitro efficacy of the recombinant bacteriophage endolysin HY-133 against the small-colony variant (SCV) phenotype of Staphylococcus aureus.
- To assess HY-133's activity against both methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains, including those with functional resistance.
Main Methods:
- Minimal inhibitory (MIC) and minimal bactericidal concentrations (MBC) of HY-133 were determined for clinical SCVs, their isogenic wild types, and gentamicin-selected SCVs.
- Time-kill studies were conducted to compare the bactericidal activity of HY-133 with oxacillin.
Main Results:
- HY-133 demonstrated rapid bactericidal activity against all tested Staphylococcus aureus strains and phenotypes, with MIC and MBC values ranging from 0.12 to 1 mg/L.
- HY-133 achieved a ≥3-log10 decrease in CFU/mL within 1 hour, significantly faster than oxacillin (4-24 hours).
- The efficacy of HY-133 was independent of growth phase, resistance pattern, and SCV phenotype.
Conclusions:
- Recombinant bacteriophage endolysin HY-133 exhibits potent and rapid in vitro bactericidal activity against Staphylococcus aureus, including SCV phenotypes.
- HY-133's efficacy and independence from traditional resistance mechanisms make it a promising candidate for novel decolonization strategies against Staphylococcus aureus.
Related Concept Videos
Lysogenic Cycle of Bacteriophages
Lytic Cycle of Bacteriophages
Histone Variants at the Centromere
DNA Bacteriophages
Types of Genetic Transfer Between Organisms
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

